GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gencurix Inc (XKRX:229000) » Definitions » Institutional Ownership

Gencurix (XKRX:229000) Institutional Ownership : 3.43% (As of May. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Gencurix Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Gencurix's institutional ownership is 3.43%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Gencurix's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Gencurix's Float Percentage Of Total Shares Outstanding is 0.00%.


Gencurix Institutional Ownership Historical Data

The historical data trend for Gencurix's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gencurix Institutional Ownership Chart

Gencurix Historical Data

The historical data trend for Gencurix can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 0.60 0.60 4.65 4.73 4.58 4.99 3.26 3.07 3.07 3.43

Gencurix Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Gencurix (XKRX:229000) Business Description

Traded in Other Exchanges
N/A
Address
9th Floor, Hanhwa Bizmetro I, Guro 3-dong, Guro-gu, Seoul, KOR, 152-733
Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.

Gencurix (XKRX:229000) Headlines

No Headlines